Skip to main content

Table 3 Adverse effects observed in JDM cohort (n = 31)

From: Favorable outcomes with reduced steroid use in juvenile dermatomyositis

Fractures (n = 4) Talus (n = 1)
Multiple thoracic vertebrae, T6-T10, T12 (n = 1)
Avulsion fracture of the 3rd finger (n = 1)
Distal tibia (following trauma) (n = 1)
Avascular necrosis (n = 2) Knees bilaterally (n = 1)
Ankle bones (n = 1)
Infections (n = 8) a RSV (n = 1)
Campylobacter (n = 1)
Oral thrush (n = 3)
Cellulitis (n = 1)
Pleural effusion (n = 1)
Impetigo (n = 1)
Vaginal candidiasis (n = 1)
Viral meningitis (n = 1)
Pneumonia (n = 1)
Streptococcal bacteremia (n = 1)
CMV reactivation (n = 1)
Herpes zoster (n = 2)
Growth (n = 2) Short stature (n = 1)
Poor weight gain (n = 1)
  1. a3 patients had multiple infections